JP2007500005A5 - - Google Patents

Download PDF

Info

Publication number
JP2007500005A5
JP2007500005A5 JP2006521655A JP2006521655A JP2007500005A5 JP 2007500005 A5 JP2007500005 A5 JP 2007500005A5 JP 2006521655 A JP2006521655 A JP 2006521655A JP 2006521655 A JP2006521655 A JP 2006521655A JP 2007500005 A5 JP2007500005 A5 JP 2007500005A5
Authority
JP
Japan
Prior art keywords
human
treated
per day
rosuvastatin
statins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006521655A
Other languages
English (en)
Japanese (ja)
Other versions
JP4166257B2 (ja
JP2007500005A (ja
Filing date
Publication date
Priority claimed from GBGB0317592.4A external-priority patent/GB0317592D0/en
Application filed filed Critical
Publication of JP2007500005A publication Critical patent/JP2007500005A/ja
Publication of JP2007500005A5 publication Critical patent/JP2007500005A5/ja
Application granted granted Critical
Publication of JP4166257B2 publication Critical patent/JP4166257B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006521655A 2003-07-26 2004-07-26 ヒトにおけるスタチン薬物動態に対する効果と関連するヒトoatp−cにおける多型のスタチン療法での使用 Expired - Fee Related JP4166257B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0317592.4A GB0317592D0 (en) 2003-07-26 2003-07-26 Method
PCT/GB2004/003236 WO2005012566A2 (en) 2003-07-26 2004-07-26 Use of polymorphisis in human oatp-c associated with an effect on statin pharmacokinetics in humans in statin therapy

Publications (3)

Publication Number Publication Date
JP2007500005A JP2007500005A (ja) 2007-01-11
JP2007500005A5 true JP2007500005A5 (cg-RX-API-DMAC7.html) 2007-09-13
JP4166257B2 JP4166257B2 (ja) 2008-10-15

Family

ID=27772801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006521655A Expired - Fee Related JP4166257B2 (ja) 2003-07-26 2004-07-26 ヒトにおけるスタチン薬物動態に対する効果と関連するヒトoatp−cにおける多型のスタチン療法での使用

Country Status (12)

Country Link
US (1) US7700277B2 (cg-RX-API-DMAC7.html)
EP (1) EP1651774B1 (cg-RX-API-DMAC7.html)
JP (1) JP4166257B2 (cg-RX-API-DMAC7.html)
AT (1) ATE373730T1 (cg-RX-API-DMAC7.html)
CY (1) CY1107801T1 (cg-RX-API-DMAC7.html)
DE (1) DE602004009083T2 (cg-RX-API-DMAC7.html)
DK (1) DK1651774T3 (cg-RX-API-DMAC7.html)
ES (1) ES2291899T3 (cg-RX-API-DMAC7.html)
GB (1) GB0317592D0 (cg-RX-API-DMAC7.html)
PL (1) PL1651774T3 (cg-RX-API-DMAC7.html)
PT (1) PT1651774E (cg-RX-API-DMAC7.html)
WO (1) WO2005012566A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006008656A2 (en) * 2004-07-21 2006-01-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) Oatp-c gene c463a polymorphism underlies variable response of statin therapy
WO2009106838A1 (en) * 2008-02-29 2009-09-03 Isis Innovation Limited Diagnostic methods
US9817001B2 (en) 2008-05-27 2017-11-14 Boston Heart Diagnostics Corporation Methods for determining LDL cholesterol treatment
US8470541B1 (en) 2008-09-27 2013-06-25 Boston Heart Diagnostics Corporation Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
CA2851838A1 (en) 2011-10-13 2013-04-18 Boston Heart Diagnostics Corporation Compositions and methods for treating and preventing coronary heart disease
US9828624B2 (en) 2013-07-24 2017-11-28 Boston Heart Diagnostics Corporation Driving patient compliance with therapy
CA2968221A1 (en) 2014-11-17 2016-05-26 Boston Heart Diagnostic Corporation Cardiovascular disease risk assessment
US10572811B2 (en) * 2015-01-29 2020-02-25 Splunk Inc. Methods and systems for determining probabilities of occurrence for events and determining anomalous events
MY204234A (en) 2018-08-27 2024-08-16 Regeneron Pharma Use of raman spectroscopy in downstream purification
CN110904215A (zh) * 2019-12-16 2020-03-24 西安和合医学检验所有限公司 用于同步检测slco1b1基因的两个snp位点的基因多态性的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32011A (en) * 1861-04-09 Coffee-pot
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4411993A (en) 1981-04-29 1983-10-25 Steven Gillis Hybridoma antibody which inhibits interleukin 2 activity
USRE32011E (en) 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4543439A (en) 1982-12-13 1985-09-24 Massachusetts Institute Of Technology Production and use of monoclonal antibodies to phosphotyrosine-containing proteins
US4902614A (en) 1984-12-03 1990-02-20 Teijin Limited Monoclonal antibody to human protein C
IE61148B1 (en) 1988-03-10 1994-10-05 Ici Plc Method of detecting nucleotide sequences
GB8902689D0 (en) 1989-02-07 1989-03-30 Ici Plc Assay method
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
EP0728218B1 (en) 1993-11-12 2008-01-02 PHRI Properties, Inc. Hybridization probes for nucleic acid detection, universal stems, methods and kits
WO2000008157A2 (en) 1998-08-07 2000-02-17 Axys Pharmaceuticals, Inc. Human anion transporter genes atnov
US20020090622A1 (en) * 2000-08-23 2002-07-11 Monisola Adeokun Chemical compounds

Similar Documents

Publication Publication Date Title
Melzer et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs)
Canaparo et al. Expression of CYP3A isoforms and P‐glycoprotein in human stomach, jejunum and ileum
Han et al. Genome-wide association reveals genetic effects on human Aβ 42 and τ protein levels in cerebrospinal fluids: a case control study
Green et al. P2RX7: A bipolar and unipolar disorder candidate susceptibility gene?
Hirvensalo et al. UGT1A3 and sex are major determinants of telmisartan pharmacokinetics—a comprehensive pharmacogenomic study
Prata et al. Association of DAO and G72 (DAOA)/G30 genes with bipolar affective disorder
JP2016540729A5 (cg-RX-API-DMAC7.html)
CN114568028A (zh) 用于诊断阿尔茨海默病的遗传变体
Kang et al. Polymorphisms of the leptin and HTR2C genes and clozapine-induced weight change and baseline BMI in patients with chronic schizophrenia
Jones et al. Evaluating a causal relationship between complement factor I protein level and advanced age-related macular degeneration using mendelian randomization
Niessner et al. Fractalkine receptor polymorphisms V249I and T280M as genetic risk factors for restenosis
Akomolafe et al. Genetic association between endothelial nitric oxide synthase and Alzheimer disease
Cunningham et al. Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers
AU773765B2 (en) Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of variant GPIIIA and/or variant GPIIB allele
Zuo et al. The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation
JP4166257B2 (ja) ヒトにおけるスタチン薬物動態に対する効果と関連するヒトoatp−cにおける多型のスタチン療法での使用
Lai et al. Negative association between catechol-O-methyltransferase (COMT) gene Val158Met polymorphism and persistent tardive dyskinesia in schizophrenia
Korovaitseva et al. Alpha-2 macroglobulin gene in early-and late-onset Alzheimer disease
Calle et al. Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76
Uchida et al. No association between the sigma receptor type 1 gene and schizophrenia: results of analysis and meta-analysis of case-control studies
Ali et al. Association study of Klotho gene polymorphism with calcium oxalate stones in the Uyghur population of Xinjiang, China
Tranah et al. Mitochondrial DNA m. 13514G> A heteroplasmy is associated with depressive symptoms in the elderly
Li et al. Significance of sarcomere gene mutation in patients with dilated cardiomyopathy
KR101883631B1 (ko) 심장 질환 후 우울증 진단을 위한 정보 제공 방법 및 진단용 키트
Alina et al. Thr92Ala polymorphism of human type 2 deiodinase gene (hD2) affects the development of Graves′ disease, treatment efficiency, and rate of remission